user-avatar
The Manila Times

Insight Molecular Diagnostics Announces Proposed Public Offering

The company has commenced an underwritten public offering of common stock and prefunded warrants. It intends to grant the underwriter a 30-day over-allotment option to purchase up to an additional 15% of the shares.